Efficacy and Safety of Ombitasvir/Paritaprevir/ Ritonavir + Dasabuvir ± Ribavirin Combinations in Patients with Genotype 1 Hepatitis C and Inherited Bleeding Disorders.

Abdullah Sonsuz,Selma Bozcan,İbrahim Hatemi,Sebati Özdemir,Billur Canbakan,Süleyman Yıldırım, İlkay Gültürk, Cem Ar

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology（2022）

引用 0|浏览3

暂无评分

摘要

Ombitasvir + paritaprevir combined with ritonavir and dasabuvir ± ribavirin is an effective treatment for patients infected with genotype 1 hepatitis C who have coagulation disorders. Tolerance and side effects are similar to other treatment options.

查看译文

关键词

Chronic viral hepatitis, direct-acting antivirals, hemophilia, inherited coagulation disorders, von Willebrand disease

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要